Download PDF
Dtsch Med Wochenschr 2014; 139(25/26): 1373-1376
DOI: 10.1055/s-0034-1370130
Aktuelle Diagnostik und Therapie | Review article
Infektiologie
© Georg Thieme Verlag KG Stuttgart · New York

Azol-Resistenz bei Aspergillus fumigatus – Epidemiologie und Nachweis bei immunsupprimierten Patienten in Deutschland

Azole resistance in Aspergillus fumigatus – epidemiology and detection in immunocompromised patients in Germany
D. Buchheidt
1   3. Medizinische Klinik, Universitätsmedizin Mannheim
,
B. Spiess
1   3. Medizinische Klinik, Universitätsmedizin Mannheim
,
O. A. Cornely
2   Klinik I für Innere Medizin, Universitätsklinikum Köln
3   Clinical Trials Centre Cologne (ZKS Köln, BMBF 01KN1106), Center for Int egrated Oncology CIO Köln/Bonn
,
M. J. G. T. Vehreschild
2   Klinik I für Innere Medizin, Universitätsklinikum Köln
,
A. Hamprecht
4   Institut für Medizinische Mikrobiologie, Immunologie und Hygiene, Universi-tätsklinikum Köln
,
P.-M. Rath
5   Institut für Medizinische Mikrobiologie, Universitätsklinikum Essen
,
J. Steinmann
5   Institut für Medizinische Mikrobiologie, Universitätsklinikum Essen
,
U. Groß
6   Institut für Medizinische Mikrobiologie, Universitätsmedizin Göttingen
,
O. Bader
6   Institut für Medizinische Mikrobiologie, Universitätsmedizin Göttingen
,
M. Lauten
7   Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Schleswig-Holstein, Campus Lübeck
,
M. Reinwald
1   3. Medizinische Klinik, Universitätsmedizin Mannheim
,
W.-K. Hofmann
1   3. Medizinische Klinik, Universitätsmedizin Mannheim
› Author Affiliations
Further Information

Publication History

31 January 2014

03 April 2014

Publication Date:
10 June 2014 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

Azol-Resistenz - Aspergillose

Keywords

azole resistence - aspergillosis
 

  • Literatur

  • 1 Alcazar-Fuoli L, Mellado E. Ergosterol biosynthesis in Aspergillus fumigatus: its relevance as an antifungal target and role in antifungal drug resistance. Front Microbiol 2012; 3: 439
    PubMedSearch in Google Scholar
  • 2 Arikan-Akdagli S. Azole resistance in Aspergillus: global status in Europe and Asia. Ann N Y Acad Sci 2012; 1272: 9-14
    CrossrefPubMedSearch in Google Scholar
  • 3 Bader O, Weig M, Reichard U et al. cyp51A-based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany. Antimicrob Agents Chemother 2013; 57: 3513-3517
    CrossrefPubMedSearch in Google Scholar
  • 4 Camps SM, van der Linden JW, Li Y et al. Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature. Antimicrob Agents Chemother 2012; 56: 10-16
    CrossrefPubMedSearch in Google Scholar
  • 5 Hamprecht A, Buchheidt D, Vehreschild JJ et al. Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany. Euro Surveill 2012; 17: 20262
    PubMedSearch in Google Scholar
  • 6 Howard SJ, Webster I, Moore CB et al. Multi-azole resistance in Aspergillus fumigatus. Int J Antimicrob Agents 2006; 28: 450-453
    CrossrefPubMedSearch in Google Scholar
  • 7 Karthaus M, Buchheidt D. Invasive aspergillosis: new insights into disease, diagnostic and treatment. Curr Pharm Des 2013; 19: 3569-3594
    CrossrefPubMedSearch in Google Scholar
  • 8 Mellado E, Garcia-Effron G, Buitrago MJ et al. Targeted gene disruption of the 14-alpha sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility. Antimicrob Agents Chemother 2005; 49: 2536-2538
    CrossrefPubMedSearch in Google Scholar
  • 9 Rath PM, Buchheidt D, Spiess B et al. First reported case of azole-resistant Aspergillus fumigatus due to the TR/L98H mutation in Germany. Antimicrob Agents Chemother 2012; 56: 6060-6061
    CrossrefPubMedSearch in Google Scholar
  • 10 Ruhnke M, Böhme A, Buchheidt D et al. Diagnosis of invasive fungal infections in hematology and oncology – guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO). Ann Oncol 2012; 23: 823-833
    CrossrefPubMedSearch in Google Scholar
  • 11 Skladny H, Buchheidt D, Baust C et al. Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCR. J Clin Microbiol 1999; 37: 3865-3871
    PubMedSearch in Google Scholar
  • 12 Snelders E, Camps SM, Karawajczyk A et al. Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus. PLoS One 2012; 7: e31801
    CrossrefPubMedSearch in Google Scholar
  • 13 Spiess B, Seifarth W, Merker N et al. Development of novel PCR assays to detect azole resistance-mediating mutations of the Aspergillus fumigatus cyp51A gene in primary clinical samples from neutropenic patients. Antimicrob Agents Chemother 2012; 56: 3905-3910
    CrossrefPubMedSearch in Google Scholar
  • 14 van der Linden JW, Camps SM, Kampinga GA et al. Aspergillosis due to voriconazole highly-resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domestic homes. Clin Infect Dis 2013; 57: 513-520
    CrossrefPubMedSearch in Google Scholar
  • 15 van der Linden JW, Snelders E, Kampinga GA et al. Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007–2009. Emerg Infect Dis 2011; 17: 1846-1854
    CrossrefPubMedSearch in Google Scholar